Bright Minds Biosciences Inc.
DRUG
CNSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/14/2025
-
MarketBeat
6/27/2026
-
Tickeron - Stocks
6/27/2026
-
Tickeron - Stocks
6/27/2026
-
Tickeron - Stocks
6/25/2026
-
Tickeron - Stocks
6/24/2026
-
Tickeron - Stocks
6/23/2026
-
Tickeron - Stocks
6/18/2026
-
The Cerbat Gem
6/15/2026
-
The Cerbat Gem
6/9/2026
-
Tickeron - Stocks
6/8/2026
-
TipRanks
6/7/2026
-
Tickeron - Stocks
6/5/2026
-
Tickeron - Stocks
Bright Minds Biosciences (DRUG, $74.3) Stochastic Oscillator left the oversold zone on June 03, 2026
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/3/2026
-
The Cerbat Gem
6/3/2026
-
TipRanks Financial Blog
6/2/2026
-
TipRanks Financial Blog
5/29/2026
-
Tickeron - Stocks
5/28/2026
-
TipRanks Financial Blog
5/28/2026
-
Tickeron - Stocks
5/27/2026
-
The Cerbat Gem
5/26/2026
-
Globe Newswire
5/24/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 19, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
647 865 8622
Address
19 Vestry Street
New York, NY 10013
New York, NY 10013
Country
Year Founded
Business Description
Sector
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes...
more